Loading...
Loading...
Shares in Indivior, the London-listed maker of treatments for opioid dependence, are sharply up this morning, gaining 10pc at pixel time.
Today's statement from Indivior wasn't quite the one little old Betaville was expecting.
A takeover bid tale on Britain's Budget Day.